Skip to main content

Pregabalin

NDC 71335-1751 · Bryant Ranch Prepack

Generic namePregabalin
Dosage formCAPSULE
RouteORAL
Active ingredient(s)PREGABALIN
Strength50 mg/1
DEA scheduleCV
Marketing categoryANDA

Packages

71335-1751-1 — 30 CAPSULE in 1 BOTTLE (71335-1751-1)

71335-1751-2 — 60 CAPSULE in 1 BOTTLE (71335-1751-2)

71335-1751-3 — 90 CAPSULE in 1 BOTTLE (71335-1751-3)

71335-1751-4 — 15 CAPSULE in 1 BOTTLE (71335-1751-4)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

71209-039 — PREGABALIN, 71335-1300 — PREGABALIN, 71335-1459 — PREGABALIN, 71335-1475 — PREGABALIN, 71335-1476 — PREGABALIN, 71335-1505 — PREGABALIN, 71335-1555 — PREGABALIN, 71335-1740 — Pregabalin, 71335-1744 — PREGABALIN, 71335-1745 — Pregabalin, 71335-1758 — Pregabalin, 71335-1762 — Pregabalin, 71335-1788 — Pregabalin, 71335-1789 — Pregabalin, 71335-1790 — Pregabalin, 71335-1791 — Pregabalin, 71335-1792 — Pregabalin, 71335-1822 — Pregabalin, 71335-2339 — PREGABALIN, 71335-2343 — PREGABALIN, +519 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels